Renal news roundup from AKF

Researchers have found that levels of renalase, dopamine and norepinephrine vary significantly in patients with CKD based on the type of renal replacement thera...

Sodium-glucose cotransporter-2 inhibitors (SGLT2) significantly reduce total cholesterol levels in CKD patients, regardless of diabetes status, according to a s...

Swiss pharmaceutical firm Novartis has agreed to acquire Regulus Therapeutics for $800 million upfront and as much as $1.7 billion total, targeting the experime...

Kidney disease has become the third-fastest-growing cause of death globally, according to data from the Centers for Disease Control and Prevention (CDC) and oth...

A study in Critical Care finds that sepsis-associated acute kidney injury (SA-AKI) affects nearly half of intensive care unit (ICU) patients with sepsis, with 2...

Patients with chronic obstructive pulmonary disease (COPD) have a higher risk of AKI and acute kidney disease (AKD), according to a study in the journal Renal F...

An American Academy of Sleep Medicine position paper, published in the Journal of Clinical Sleep Medicine, describes excessive sleepiness as a serious health ri...

Research in the European Journal of Internal Medicine found that patients with hyponatremia had higher 30-day mortality rates compared with those who had normal...

Cardiovascular-kidney-metabolic (CKM)-related mortality rates tend to be higher in U.S. rural areas than in large metro areas, according to a study presented at...